These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22265717)

  • 1. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.
    Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ
    Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-invasive oral squamous cell carcinoma in cats: pathology and expression of parathyroid hormone-related protein.
    Martin CK; Tannehill-Gregg SH; Wolfe TD; Rosol TJ
    Vet Pathol; 2011 Jan; 48(1):302-12. PubMed ID: 20940448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
    Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
    J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
    Hwang YS; Lee SK; Park KK; Chung WY
    Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.
    Martin CK; Dirksen WP; Carlton MM; Lanigan LG; Pillai SP; Werbeck JL; Simmons JK; Hildreth BE; London CA; Toribio RE; Rosol TJ
    Vet Comp Oncol; 2015 Sep; 13(3):203-17. PubMed ID: 23651067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
    Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
    J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma.
    Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M
    Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats.
    Wypij JM; Fan TM; Fredrickson RL; Barger AM; de Lorimier LP; Charney SC
    J Vet Intern Med; 2008; 22(1):158-63. PubMed ID: 18289304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
    Elmusrati AA; Pilborough AE; Khurram SA; Lambert DW
    Br J Cancer; 2017 Sep; 117(6):867-875. PubMed ID: 28742795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.
    Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
    Childs Nerv Syst; 2013 Jul; 29(7):1097-105. PubMed ID: 23559392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
    Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
    Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.
    Martin CK; Werbeck JL; Thudi NK; Lanigan LG; Wolfe TD; Toribio RE; Rosol TJ
    Cancer Res; 2010 Nov; 70(21):8607-16. PubMed ID: 20959474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.